who

Whole genome fine map of rice completed

After the completion of a draft sequence of the Chinese hybrid rice genome, which was published in the Journal Science in 2002, CAS researchers have recently finished the fine map of the rice genome. In an article published by the recent issue of PLoS Biology (Vol.3 Issue 2, 2005), scientists led by the Beijing Institute of Genomics (BIG) reported a "much improved, near-complete genome analysis o...

New insight into people who 'see' colors in letters and numbers

People with a form of synesthesia in which they see colors when viewing letters and numbers really do see colors, researchers, led by Edward M. Hubbard of the University of California San Diego, have found. What's more, functional magnetic resonance imaging (fMRI) of their brains reveals that they show activation of color-perception areas. The researchers said their findings lend support t...

Rush Physicians Using Gene Therapy For Heart Patients With Moderate To Severe Chest Pains Who Do Not Benefit From Other Treatments

Individuals with moderate to severe chest pains (angina) who have not found relief from medication may benefit from a new gene therapy approach being used by cardiologists at Rush University Medical Center to grow new blood vessels in the heart. The phase II clinical research study uses vascular endothelial growth factor-2 (VEGF-2) in the form of a solution containing a DNA plasmid that i...

WHO Warns Of Increased Risk Of Vector-borne Diseases In Tsunami-affected Areas

The World Health Organization (WHO) warned about increased risk of vector-borne diseases such as malaria and dengue fever across tsunami-affected areas in Southeast Asia. Nearly four weeks after the disaster struck the region on 26 December, the organization is strengthening its disease surveillance, stagnant water conditions creating conditions for mosquito vectors to multiply to sufficient leve...

WHO suspends Marburg work, appeals for new funds

As of 7 April, 205 cases of Marburg haemorrhagic fever have been reported in Angola. Of these, 180 have died. Zaire Province has reported its first 6 cases, bringing the number of affected provinces to seven, all concentrated in the north-western part of the country. Mobile surveillance teams in Uige were forced to suspend operations yesterday when vehicles were attacked and damaged by loc...

More>>

who at Biology Products

S. pombe Whole Genome ChIP-on-chip from Agilent Technologies

Description:The S. pombe Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. pombe) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering both...
Company:Agilent Technologies

S. cerevisiae yeast Whole Genome from Agilent Technologies

Description:The Yeast Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. cerevisiae) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering bo...
Company:Agilent Technologies

S. cerevisiae yeast Whole Genome from Agilent Technologies

Description:The Yeast Whole Genome ChIP-on-chip Microarray is specifically designed for location analysis of yeast (S. cerevisiae) DNA binding proteins by pairing chromatin immunoprecipitation (ChIP) with Agilent DNA microarrays. This set delivers robust hybridization and reliable binding data with greater true binding events and fewer false positives. In addition, Agilent provides flexibility by offering bo...
Company:Agilent Technologies

GenomePlex Single Cell Whole Genome Amplification Kit from Sigma-Aldrich

Description:GenomePlex Single Cell Whole Genome Amplification Kit utilizes a proprietary technology based on random fragmentation of genomic DNA and conversion of the resulting small fragments to PCR-amplifiable library molecules flanked by universal priming sites. WGA is achieved by PCR amplification of the library molecules using universal oligonucleotide primers....
Company:Sigma-Aldrich

GenomePlex Whole Genome Amplification (WGA) kit from Sigma-Aldrich

Description:...
Company:Sigma-Aldrich

More>>

who at Biology Technology

Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood

...

Fractionation of Bovicola ovis Homogenates Using the Mini Whole Gel Eluter

Brian J. Shiell and Wojtek P. Michalski, CSIRO Division of Animal Health,Australian Animal Health Laboratory, Geelong, Victoria, Australia Introduction Amino acid sequence and composition analyses of proteins can be performed on samples derived from polyacrylamide gels. Protein electro-elution, the most c...

Who owns software developed for your company?

Even when there is a written contract, the specifics of ownership of the intellectual property in the software are often no...

Whole Genomes From Microbes to Man

Madison, WI-- Optical Mapping is a new technology that will be used to discover why patients experience toxic side effects, or fail to respond to medication and to identify the causes of antibiotic resistance and virulence in pathogenic organisms. Wisconsin- based OpGen, has announced the commercial launch of its Optical Mapping(TM) system for rapid, cost-effective analysis of whole genomes, from...

WHOLE GENOME SEQUENCING

Agencourt offers whole genome services that can encompass all aspects of genome projects from shotgun library construction through genome annotation and pathway mapping. Our personal project managers consult with clients to design a sequencing strategy to meet their specific project goals and are available to manage th...

More>>

who at Medicine News

No harm in reducing prenatal check up to 3 - 6 times says WHO report

A world health organisation report says that women with low risk pregnancies, who live in the developing nations, can safely cut down their vists to the doctor during pregnancy to 3 - 6 times during pregnancy instead of the prescribed 8 - 11 visits as in the developed nations. However, these women are not more at risk than women who had more prenatal visits to have a low birth weight bab...

Half of world's children are passive smokers - damning disclosure from WHO

The world health organisation has come out with a damning disclosure that half the world's children are passive smoke. In a message on "No Tobacco Day 2001," World Health Organization chief Gro Harlem Brundtland said 700 million children were exposed to the health hazard because most governments still allowed smoking in public places. She added that scientists around the world agreed that...

WHO acts to reduce the maternal death toll

According to a WHO report more than half a million women in developing countries dies of childbirth each year. WHO and the Partnership for Safe Motherhood and Newborn Health //are intensifying support to countries around the world to ensure that a woman does not die while giving birth to her child. The report indicates that the needs are wide-ranging - from training skilled birth atte...

Human Bird Flu Cases Total 130: WHO

With laboratory confirmations of new bird flu cases in China and Indonesia, the World Health Organization (WHO) reports that on November 17, 130 humans had been stricken with the H5N1 // avian influenza virus that has resulted in the death or destruction of more than 150 million birds. More than half the people infected – 67 – have died from the disease. WHO affirms the announc...

Global Warming Could Cause 5 Million Illnesses: WHO

These findings were reached after a comprehensive study conducted by the scientists at the University of Wisconsin at Madison. These researchers entered data on climate-sensitive diseases // into mapping software and reached their conclusions. The WHO data also shows that the worst affected by the climate change are the poor countries, who are not responsible for the phenomenon in any way...

More>>

who at Medicine Products

Series 590 Low Cost Whole Blood Aggregometers

Description:Chrono-log's wide range of Platelet aggregometers allows to choose the instrument capabilities to meet particular needs. Single, dual and four sample units are available, with chart recorder outputs or digital computer outputs. In addition to the Chrono-log Optical aggregometers, which measure platelet aggregation in platelet-rich-plasma (PRP), Chrono-log supplies: Whole blood aggregometers which...
Company:Chrono-log Corporation

ACCUTEST Mononucleosis Whole Blood Test

Description:The Accutest Infectious Mononucleosis Whole Blood Test is a rapid visual test used for the detection of IgM antibodies specific to infectious mononucleosis (IM) in human whole blood. This test kit can be used to help in the diagnosis of IM in patients with clinical symptoms common to IM....
Company:JANT Pharmacal Corp.

ACCUTEST H. pylori Test (Whole Blood)

Description:The Accutest H. pylori WB test is a rapid test for the qualitative detection of lgG antibodies specific to Helicobacter pylori in human whole blood. This test kit is intended as an aid in the diagnosis of H.pylori infection in patients with gastrointestinal symptoms....
Company:JANT Pharmacal Corp.

SST-1 Whole-field Scotopic Sensitivity Tester

Description:Whole-field scotopic sensitivity (threshold) testing provides clinically beneficial information in a wide variety of ophthalmic conditions. Dark adaptometry is useful in the diagnosis and management of retinal degenerations, senile miosis, high myopia, vitamin-A deficiency, and other night blinding conditions, while whole-field scotopic sensitivity has been shown to be useful in the early detecti...
Company:LKC Technologies, Inc.

Liquichek Whole Blood Volatiles Control

Description:Liquichek Whole Blood Volatiles Control is an assayed liquid control for monitoring volatile compounds. This product is available in 2 levels....
Company:Bio-Rad Laboratories

More>>

who at Medicine Technology

Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies

The Epstein Barr virus (EBV), which causes infectious mononucleosis (IM), is one of the most common human viruses. EBV occurs worldwide, and most people become infected with EBV sometime during their lives. In the United States, as many as 95 percent of adults between 35 and 40 years of age have been infected. In most developed countries, including the U.S., infection with EBV most often occu...

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - Pfizer announced todaythat Lipitor (atorvastatin calcium) Tablets 80 mg reduced the riskof stroke, coronary heart disease events and major coronary eventsin type 2 diabetes patients who had no known coronary heart diseasebut who had experienced a recent stroke or mini-stroke, comparedwith placebo. The results are from a new analysis of the landmarkSt...

Valopicitabine Combined with Standard of Care Cleared Hepatitis C Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a Phase II Trial

~ Valopicitabine achieved both primary and secondary endpoints ofstudy; no negative drug-drug interaction was observed betweenvalopicitabine and ribavirin ~ CAMBRIDGE, Mass., June 12, 2007 /PRNewswire-FirstCall/ -- IdenixPharmaceuticals, Inc. today announced results from a phase II studydesigned to evaluate triple combination therapy, consisting ofvalopicitabine (NM283), Idenix's lead dru...

FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications

ROCKVILLE, Md., May 2, 2007-The U.S. Food and DrugAdministration (FDA) today proposed that makers of allantidepressant medications update the existing black box warning ontheir products' labeling to include warnings about increased risksof suicidal thinking and behavior, known as suicidality, in youngadults ages 18 to 24 during initial treatment (generally the firstone to two months).</p...

Baraclude (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

93 Percent of Nucleoside-Naive Chronic Hepatitis B e-Antigen(HBeAg)-Negative Patients Achieved Undetectable Viral Load by Week48 of Re-Treatment PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstCall/ --Bristol-Myers Squibb Company today announced data from a cohort ofnucleoside-naive HBeAg-negative chronic hepatitis B patients(ETV-027/901, n=99). These data showed that patients whoexperi...

More>>

who at Medicine Dictionary

Whooping cough

pertuss...